Prof. Dr. Alfredo-Obregón, Dr. Alex Tai and their team from the National University of Singapore are pioneering a novel magnetic therapy for the treatment of breast cancer. The combination of non-invasive and painless magnetic pulses complements chemotherapy and potentially lowers side effects.
The magnetic technology increases cellular oxygen respiration. In breast tumor cells, the magnetic pulses cause the cancer cells to ‘hyperventilate’ and die, whereas healthy cells are able to tolerate the increased respiratory rate.
To further validate their findings, the research team plans to start a first-in-human safety trial. The one-year clinical trial is expected to involve about 30 breast cancer patients who will undergo the magnetic therapy in combination with chemotherapy.
For more information please visit: NUS news